S100A6 and prostate adenocarcinoma: Immunostaining for S100A6 showed that in all 66 cases of benign epithelium adjacent to prostatic adenocarcinoma, the staining was seen to be intense in the nuclei and cytoplasm of basal cells, with luminal cells showing an absence of staining.